restructuring
OraSure Technologies Restructures Business as Q4 Revenues Nearly Double
The company is combining its Molecular Solutions and Diagnostics business units, a move that is expected to save it about $15 million annually.
Epigenomics Announces Layoffs, Product Line Cancellation in Restructuring
The firm is halting sale of Epi proColon and recalling the product as well as reducing its employee headcount after failing to raise additional capital.
Invitae Bets on Oncology Portfolio to Drive Growth as it Streamlines, Integrates Test Services
Premium
In the wake of last year's massive restructuring, Invitae is focused on developing its Personalized Cancer Monitoring product while integrating other oncology offerings.
Quanterix Restructuring Efforts on Track, CEO Says at JP Morgan Conference
The restructuring is to scale its operations and assays to better meet both current and anticipated demand for higher-throughput testing, its CEO said.
Rebranded GeneDx Bets Future on Whole-Exome, Whole-Genome Sequencing in Pediatric Rare Disease
Premium
After dropping underdeveloped Sema4 business lines but emphasizing the Centrellis informatics platform, the new GeneDx expects to reach profitability by 2025.